Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DIACC-3010 by Evexta Bio for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
Data Insights
DIACC-3010 by Evexta Bio for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...